Bridged Bicyclic Compounds and their Derivatives as Neuroprotective Agents


This technology utilizes bridged bicyclic compounds and pharmaceutically acceptable salt forms as neuroprotective agents. The compounds have been benchmarked against resveratrol and have shown neuroprotective properties relative to it. One of the compounds provided extended time to synaptic failure by approximately 100 minutes. Additionally, another tested compound allowed the synapse under study to maintain 80% of its normal function even under declining oxidative conditions. Initial studies show these compounds are capable of restoring synaptic function after oxidative stress.

Patent Information:
For Information, Contact:
Dana Vouglitois
Florida Atlantic University
Salvatore Lepore
Kenneth Dawson-Scully
Elijah St. Germain
Wesley Bollinger
Samantha Maki
© 2024. All Rights Reserved. Powered by Inteum